Discovery Antibodies产品代理
Discovery Antibodies产品代理
Discovery® Antibodies 将专注于用于研究的抗体（早期药物“发现”），并将补充我们非常成功且长期存在的定制抗体业务 (www.crbdiscovery.com)。我们已经以新颖、复杂、稀有和翻译后修饰的特异性抗体而闻名，这些备受追捧的目标将出现在我们的 Discovery® 抗体目录中。
我们于 2017 年 2 月推出了我们的 Discovery® Antibodies，距 Discovery® Peptides 一年后，也是在 James Cook 船长（他那个时代最伟大的探险家）于 1776 年乘坐“HMS Discovery”号从英国启程以包租新水域和“在全球发现新的土地。因此，“发现”这个名字似乎很适合一家位于东北部的制造商——詹姆斯库克的家乡。
在 1700 年代后期对世界各地新发现的土地的探索与 2000 年医学研究和人类基因组图谱的新“发现”之间出现了进一步的相似之处。
Cambridge Research Biochemicals (www.crbdiscovery.com) 成立于 1980 年，是英国领先的定制肽和抗体工具独立生产商，为全球制药、生命科学和学术领域的研究人员提供服务。其产品的主要应用是作为定制的实验室规模试剂，用于证明早期药物发现中的主要研究，并支持临床研究中的生物标志物计划。该公司生产各种口味的肽，从简单到修饰、稳定和放射性标记，再到从毫克到克级到最高纯度的染料标记。此外，CRB 是生产高度特异性和靶向抗体（多克隆和单克隆）的公认专家。荧光染料标记也是一个重点。 2016 年，该公司推出了自 1994 年以来的第一个目录业务 DISCOVERY®
Discovery® Antibodies is Cambridge Research Biochemicals' catalogue antibody business.
CRB, the 2nd oldest peptide company in the world and forerunner in the antibody research market is now building a collection of newly validated target antibodies under the banner of Discovery® Antibodies.
Discovery® Antibodies will focus on antibodies for research (early drug ‘discovery’) and will complement our very successful and long-standing custom antibody business (www.crbdiscovery.com). We are already well known for novel, complex, rare and post-translational modification specific antibodies and these sought after targets will feature in our Discovery® Antibody catalogue range.
We launched our Discovery® Antibodies in February 2017 a year after Discovery® Peptides and some 240 years after Captain James Cook, (the greatest explorer of his time) set off in 1776 from England aboard the ‘HMS Discovery’ to charter new waters and ‘discover’ new lands around the globe. Thus the name ‘Discovery’ seemed fitting to a North-East-based manufacturer – the home town of James Cook.
Further parallels arise between the quest for new found lands around the world in the late 1700s and new ‘discoveries’ in
medical research and the mapping of the human genome in 2000.
Cambridge Research Biochemicals (www.crbdiscovery.com) founded in 1980 is a leading British independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The primary applications of its products are as custom-made, laboratory scale reagents for proof of principal studies within early phase drug discovery and to support biomarker programmes in clinical studies. The company produces all flavours of peptides from simple to modified, stable and radio-labelled to dye labelled from milligrams to gram-scale to the highest levels of purity. In addition, CRB is a recognised expert at generating highly specific and targeted antibodies (both polyclonal and monoclonal). Fluorescent dye labelling is also a focus. In 2016 the company launched its first catalogue business DISCOVERY® since 1994.
